Stiffness after total knee arthroplasty is a common occurrence. Despite its prevalence, little is known as to which patients are at risk for poor range of motion after total knee arthroplasty. The purpose of this study was to determine the risk factors for manipulation under anesthesia (MUA) after total knee arthroplasty (TKA). Using a single institution registry, 160 patients who underwent a manipulation under anesthesia after total knee arthroplasty between 2007 and 2013 were retrospectively evaluated. Each patient was 1:1 matched by age, gender and laterality to a control group of 160 patients who did not require MUA after TKA. Risk factors for MUA were assessed, and included medical co-morbidities, BMI, prior operations, and preoperative range of motion.Introduction
Methods
There were 70000 people admitted to hospital with fractured hips in 2007 and the incidence is rising by 2% each year. Hip fractures represent significant morbidity and mortality to patients and cost the NHS £1.8 billion annually. In 2008 the British Orthopaedic Association Standards for Trauma (BOAST) issued a 14-point guideline to be followed for the management of hip fractures. The aim was to improve secondary prevention of osteoporosis, reduce the falls risk and further fractures. This aimed to provide better care to improve the outcomes for patients and reduce the burden of hip fractures on society. The aim of the audit was to see if the BOAST guidelines are met before and after the transition to a level 1 MTC (Major Trauma Centre) and to measure any impact the change had. Methods: Prospective data was collected for three months in 2010, 2011 and 2012. 94 case notes were reviewed and compared to the outcomes laid out in the BOAST guidelines to see if standards were met. Overall adherence to the guideline's recommendations was high throughout the 3 sample months. For each of the 3 sample months 100% adherence was seen in all of the following criteria: further imaging if x-rays unclear, appropriate analgesia, pre-op assessment, seniority of surgeon, orthogeriatrician involvement, seniority of surgeons and submission to the National Hip Fracture Database. The main common area where adherence was less than 100% was with A and E breaches (i.e. greater than 4 hours referral to the ward). Despite relocation and transition to a level 1 MTC, the management of fractured neck of femur patients compared to the BOAST guidelines remained of a high standard. Further improvements have also been made since moving to the new hospital site where shortcomings in management have been identified. Improvements from year one to three include prophylactic antibiotics and warfarin reversal; there is now a new trust protocol in place for warfarin reversal in the case of hip fractures. Elsewhere adherence to the guidelines remains high across the sample months. Confirming that despite moving to a level 1 status the trauma team continues to be performing well and managing this group appropriately. In January 2012 BOAST published a second version of the hip fracture guidelines: A and E breaches were removed from the guidelines. There have also been several new additions to the guidelines, which prompt a further re-audit in the future.
Bone marrow lesions (BMLs) have been extensively linked to the osteoarthritis (OA) disease pathway in the knee. Semi-quantitative evaluation has been unable to effectively study the spatial and temporal distribution of BMLs and consequently little is understood about their natural history. This study used a novel statistical model to precisely locate the BMLs within the subchondral bone and compare BML distribution with the distribution of denuded cartilage. MR images from individuals (n=88) with radiographic evidence of OA were selected from the Osteoarthritis Initiative. Slice-by-slice, subvoxel delineation of the lesions was performed across the paired images using the criteria laid out by Roemer (2009). A statistical bone model was fitted to each image across the cohort, creating a dense set of anatomically corresponded points which allowed BML depth, position and volume to be calculated. The association between BML and denudation was also measured semi-quantitatively by visually scoring the lesions as either overlapping or adjacent to denuded AC, or not. At baseline 75 subjects had BMLs present in at least one compartment. Of the 188 compartments with BMLs 46% demonstrated change greater than 727mm cubed, the calculated smallest detectable difference. The majority of lesions were found in medial compartments compared to lateral compartments and the patella (Figure 1A). Furthermore, in the baseline images 76.9% of all BMLs either overlapped or were adjacent to denuded bone. The closeness of this relationship in four individuals is shown in Figure 1B. The distribution of lesions follows a clear trend with the majority found in the patellofemoral joint, medial femoro-tibial joint and medial tibial compartment. Moreover the novel method of measurement and display of BMLs demonstrates that there is a striking similarity between the spatial distribution of BMLs and denuded cartilage in subjects with OA. This co-location infers the lesions have a mechanical origin much like the lesions that occur in healthy patients as a direct result of trauma. It is therefore suggested that OA associated BMLs are in fact no different from the BMLs caused by mechanical damage, but occur as a result of localised disruption to the joint mechanics, a common feature of OA.
